Cytori Therapeutics Inc. (Nasdaq:CYTX) jumped more than 10% Tuesday after the company announced a patent was issued for its Celution System technology from the U.S. Patent and Trademark Office. The patent protects the San Diego-based biomedical manufacturer’s right to produce and sell technology that processes tissues to obtain a diverse mixture of cells, including red and white blood cells. The company still is seeking U.S. regulatory approval for the device, though it is currently sold in both Europe and Asia-Pacific regions. Cytori shares traded at about $6.74 apiece.

For detailed price information and recent news stories about Cytori Therapeutics Inc., click CYTX.